Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metal-Ligand Bonds02:51

Metal-Ligand Bonds

23.5K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
23.5K
EDTA: Auxiliary Complexing Reagents01:26

EDTA: Auxiliary Complexing Reagents

1.2K
EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
1.2K
Complexation Equilibria: The Chelate Effect01:19

Complexation Equilibria: The Chelate Effect

1.0K
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
1.0K
Complexometric Titration: Ligands00:43

Complexometric Titration: Ligands

2.1K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
2.1K
Amyloid Fibrils03:03

Amyloid Fibrils

11.5K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils03:03

Amyloid Fibrils

6.2K
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Ru(ii)-arene complex with promising anti-Aβ activity.

RSC advances·2026
Same author

Evolution of spinal evoked compound action potential thresholds, visual motor thresholds, and impedances in a rodent spared nerve injury model.

Frontiers in neuroscience·2025
Same author

Ruthenium(II)-Arene Complexes with a 2,2'-Bipyridine Ligand as Anti-Aβ Agents.

Biomolecules·2025
Same author

Inhibitory Effects of Sulfur Derivatives on <i>Leishmania tarentolae</i> Cell Viability and Secreted Acid Phosphatase In Vitro.

Microorganisms·2025
Same author

Ru(II)-arene azole complexes as anti-amyloid-β agents.

Dalton transactions (Cambridge, England : 2003)·2024
Same author

Evaluating the <i>Leishmania tarentolae</i> response to inorganic strontium-based oxyfluorides.

Heliyon·2024

Related Experiment Video

Updated: Dec 25, 2025

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

12.6K

Ruthenium(iii) complexes containing thiazole-based ligands that modulate amyloid-β aggregation.

Samantha E Huffman1, Gideon K Yawson, Samuel S Fisher

  • 1Department of Chemistry, Illinois State University, Normal, IL, 61790-4160, USA. miwebb@ilstu.edu.

Metallomics : Integrated Biometal Science
|April 3, 2020
PubMed
Summary

Ruthenium(III) complexes show promise for Alzheimer's Disease (AD) therapy by targeting soluble amyloid-beta (Aβ) peptide. Thiazole ligands on these metal-based therapeutics are key to mitigating Aβ aggregation.

More Related Videos

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

8.1K
A11-positive &#946;-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

12.4K

Related Experiment Videos

Last Updated: Dec 25, 2025

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

12.6K
Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

8.1K
A11-positive &#946;-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

12.4K

Area of Science:

  • Neuroscience
  • Medicinal Chemistry
  • Materials Science

Background:

  • Alzheimer's Disease (AD) is characterized by amyloid-beta (Aβ) peptide aggregation.
  • Soluble Aβ species, not just deposits, are neurotoxic.
  • Metal-based therapeutics offer a unique approach to target soluble Aβ.

Purpose of the Study:

  • To investigate structure-activity relationships (SAR) of Ruthenium(III) complexes for AD therapy.
  • To synthesize and evaluate derivatives of NAMI-A and PMRU20 complexes.
  • To understand how ligand modifications impact Aβ aggregation inhibition.

Main Methods:

  • Synthesis of novel Ruthenium(III) complex derivatives.
  • Thioflavin T fluorescence assays.
  • Dynamic Light Scattering (DLS) and Transmission Electron Microscopy (TEM) for Aβ aggregation analysis.

Main Results:

  • Thiazole ligands significantly mitigate Aβ aggregation.
  • Ligand functional groups influence activity: NH₂ > CH₃ > H.
  • Metal center symmetry had minimal impact on therapeutic activity.

Conclusions:

  • Ruthenium(III) complexes with specific thiazole ligands are effective against Aβ aggregation.
  • Hydrogen-bonding interactions between ligands and Aβ are crucial for therapeutic efficacy.
  • These findings guide the development of novel metallotherapeutics for Alzheimer's Disease.